WIA
MBX

Wealthedge Investment Advisors’s MBX Biosciences MBX Stock Holding History

Wealthedge Investment Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,864
Closed -$87.6K – 207
2025
Q1 		$87.6K Buy
+11,864
New +$125K 0.04% 174

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wealthedge Investment Advisors's MBX Position: Q2 2025 in Review

Wealthedge Investment Advisors sold out of MBX Biosciences (MBX) in Q2 2025, closing a stake of 11,864 shares — an estimated $87.6K sold.

Wealthedge Investment Advisors first reported a position in MBX in Q1 2025 and held it in 1 quarter. The position peaked at $87.6K in Q1 2025. 88 funds tracked by Wall St. Rank hold MBX as of Q2 2025.

  • Wealthedge Investment Advisors reported no remaining MBX Biosciences position as of Q2 2025 after selling out during the quarter.
  • Wealthedge Investment Advisors sold 11,864 MBX Biosciences shares in Q2 2025, an estimated $87.6K.
  • Wealthedge Investment Advisors first reported a position in MBX Biosciences in Q1 2025 and held it in 1 quarter.
  • Wealthedge Investment Advisors's MBX Biosciences position peaked at $87.6K in Q1 2025.
  • 88 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2025.

Based on Wealthedge Investment Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.